University Hospital Olomouc
Olomouc, Czechia
Location status: Recruiting
Location contact
Iva Holuskova, MD
CONTACT
NCT Number: NCT04427163
This study will determine reference genomic, transcriptomic, proteomic and metabolomic profiles in Czech population and will evaluate its correlation with the disease phenotype.
Interested in participating?
Request Info18 year–68 year
All sexes
Observational
Olomouc, Czechia
Location status: Recruiting
Iva Holuskova, MD
CONTACT
This study will determine reference genomic, transcriptomic, proteomic and metabolomic profiles in Czech population. Initially, there will be 1000 healthy volunteers, with the planned expansion to 10.000 participants (healthy volunteers and patients with different types of disease). Formation of the reference database of healthy volunteers and their parameters will allow a correct interpretation of the potential pathological findings in patients. It is very important to obtain healthy controls from the region of the Czech Republic, Central Europe respectively; since it is not possible to reliably compere ethnically and geographically diverse populations, which have generated in a different context and where the diseases manifest with other etiology ad phenotype. Although, in the limited measure, the similar molecular data exist in foreign databases, these are not compiled from the inhabitants of the Czech Republic, Central Europe not even from Slavic population. Study participants may volunteer for archiving of remaining biological materials for future studies.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Nucleic acids sequencing, presence of proteins and metabolites.
Health status will be examined by a physician and subject will complete a health status questionnaire.
Subject will complete race and ethnicity questionnaire to make sure subjects are from the Czech population.
Time frame: 72 months
Establishment of the Healthy Volunteers Whole Genome (Exom) Reference Database typical for the population of the Czech Republic/Central Europe.
Time frame: 72 months
Whole Genome (Exom) Sequencing of the patient populations presenting various diseases. Based on the comparison with the HEALTHY VOLUNTEER REFERENCE GENOME - determination of various genetic polymorphisms (single nucleotide polymorphisms, insertions, deletions, inversions, copy-number variations etc.) and giving these into correlation with disease phenotypes.
Time frame: 72 months
Based on the reference database of healthy volunteers in the Czech Republic a potential correlations will be evaluated among genomic, proteomic and metabolomic profiles of patients and the disease phenotypes.
Contact information is provided by the study sponsor or research team.
Marian Hajduch, MD, PhD.
CONTACT
Michaela Bendova, MSc.
CONTACT
The Institute of Molecular and Translational Medicine, Czech Republic
Other
Assesment of Multiomics Profiles in Health and Disease - Corelation With the Disease Phenotype.
Acronym: ENIGMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07018128
Breathing, Mouth, Disease Attributes
MueangChonburi, Changwat Chon Buri, Thailand
View Trial DetailsNCT07112287
Disease Attributes, Disease Susceptibility
Boston, Massachusetts, United States
View Trial DetailsNCT05759143
Disease Attributes, Disease Susceptibility
Boston, Massachusetts, United States
View Trial DetailsNCT06057181
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes
Fort Wayne, Indiana, United States
View Trial Details